Credo Life Science
Posted on 27th January 2022
Choosing the Right Dexlansoprazole Manufacturer: What Pharma Companies Should Know
In the highly regulated world of pharmaceutical manufacturing, sourcing active pharmaceutical ingredients (APIs) from a reliable partner is non-negotiable. For companies seeking a dependable Dexlansoprazole Manufacturer, the decision goes beyond pricing — it involves quality, compliance, technical expertise, and long-term reliability.
Understanding Dexlansoprazole and Its Market Significance
Dexlansoprazole is the R-enantiomer of lansoprazole, a proton pump inhibitor (PPI) widely used for the treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis. Its dual delayed-release formulation allows for extended acid suppression, making it a preferred therapeutic option. With the rising global demand for high-quality PPIs, pharma companies require a Dexlansoprazole Manufacturer that combines technical precision with regulatory compliance.
What to Look for in a Dexlansoprazole Manufacturer
- GMP Certification & Regulatory Compliance: Ensure the manufacturer holds WHO-GMP, US FDA, or EU GMP certifications. These are minimum benchmarks for global market access.
- Advanced Pellet Technology: Dexlansoprazole is typically formulated as dual delayed-release pellets. Look for manufacturers experienced in multi-layer pellet coating and controlled-release technologies.
- Analytical Capabilities: A competent manufacturer should have in-house testing labs capable of conducting dissolution profiling, impurity analysis, and stability studies.
- Regulatory Documentation Support: Dossier preparation (CTD/ACTD format), DMF filing assistance, and batch record documentation are critical for seamless regulatory submissions.
- Scalability: Choose a partner that can scale from R&D batch sizes to commercial volumes without compromising quality.
Why Pellet-Based Dexlansoprazole Manufacturing Demands Specialisation
Dexlansoprazole's unique dual delayed-release mechanism requires two distinct populations of pellets — one releasing at pH 5.5 and another at pH 6.75. This complexity demands a manufacturer with deep expertise in enteric coating, fluid bed processing, and pH-responsive polymer science. Not every contract manufacturer can deliver this level of precision consistently.
Credo Life Sciences: Your Trusted Dexlansoprazole Manufacturer
Credo Life Sciences is a specialised manufacturer of modified-release pellets and APIs with extensive experience in proton pump inhibitor formulations. Our state-of-the-art facility is equipped with fluid bed processors, coating systems, and sophisticated quality control instruments. We partner with global pharma companies to supply Dexlansoprazole pellets and APIs that meet stringent quality norms.
Choosing the right Dexlansoprazole Manufacturer can determine the success of your product in international markets. With Credo Life Sciences, you gain a partner committed to quality, compliance, and innovation — every step of the way.